There is also emerging evidence suggesting that NPY contributes to tumorigenesis in several different cancer types including neuroblastoma (NB) (52), prostate (50, 53), liver (54), colon (55), and breast cancer (56, 57). This evidence concerns the gene NPY and neuroblastoma.